On April 1 the 1st ABIRISK Drug Immunogenicity Conference was held in Innsbruck, Austria. There were many highly interesting talks at this meeting, ranging from regulatory perspective by Amy Rosenberg FDA to a mathematical framework for prediction of therapeutic drug immunogenicity by Pfizer. SciCross presented an overview of the ABIRISK database, work that is done in collaboration with the IMI eTRIKS consortia.
The ABIRISK yearly general assembly and workpackage-specific meetings were held in Innsbruck the days before the conference. Here SciCross presented a tool for integration and analysis of data generated in a range of assays focused immunogenicity assessment of biopharmaceuticals. Please feel free to contact us for further discussions on this topic.